Blue Bell Private Wealth Management, Llc
Source: SEC Form 13F · as of Mar 2026Blue Bell Private Wealth Management, Llc holds 20 biotech & pharma companies tracked by BioSniper, totaling $5.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$5.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 12,719 | $3.1M |
| LLYELI LILLY & Co | 573 | $527K |
| MCKMcKesson Corporation | 543 | $470K |
| MRKMerck & Co., Inc. | 3,362 | $404K |
| AMGNAMGEN INC | 658 | $231K |
| ABBVAbbVie Inc. | 940 | $205K |
| PFEPFIZER INC | 6,812 | $191K |
| ABTABBOTT LABORATORIES | 1,667 | $171K |
| PRMEPrime Medicine, Inc. | 27,015 | $94K |
| PMPhilip Morris International Inc | 400 | $66K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 214 | $58K |
| BMYBRISTOL MYERS SQUIBB CO | 798 | $48K |
| NTLAIntellia Therapeutics, Inc. | 1,757 | $23K |
| GILDGILEAD SCIENCES, INC. | 148 | $21K |
| GMOptec International, Inc. | 193 | $14K |
| INCYIncyte Corp. | 139 | $13K |
| ARQTArcutis Biotherapeutics, Inc. | 369 | $9K |
| TWSTTwist Bioscience Corp | 166 | $8K |
| CRSPCRISPR Therapeutics AG | 101 | $5K |
| GMEDGlobus Medical Inc. | 52 | $4K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.